Tim N. Beck

1.2k total citations
28 papers, 756 citations indexed

About

Tim N. Beck is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Tim N. Beck has authored 28 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Tim N. Beck's work include Cancer-related Molecular Pathways (6 papers), Lung Cancer Research Studies (3 papers) and DNA Repair Mechanisms (2 papers). Tim N. Beck is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Lung Cancer Research Studies (3 papers) and DNA Repair Mechanisms (2 papers). Tim N. Beck collaborates with scholars based in United States, Russia and Germany. Tim N. Beck's co-authors include Erica A. Golemis, JF Rossi, Bernard Klein, J Brochier, Thierry Lavabre‐Bertrand, Bart Barlogie, R Bataille, Lu Zy, Paul Scheet and Ernest T. Hawk and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and Blood.

In The Last Decade

Tim N. Beck

25 papers receiving 740 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim N. Beck United States 14 352 298 151 125 114 28 756
Karolina Przybyłowska Poland 17 379 1.1× 241 0.8× 303 2.0× 55 0.4× 52 0.5× 48 828
Jianjun Yu China 13 455 1.3× 217 0.7× 198 1.3× 49 0.4× 276 2.4× 52 943
Emile Youssef United States 13 495 1.4× 188 0.6× 126 0.8× 86 0.7× 95 0.8× 18 713
Sophie Domhan Germany 11 400 1.1× 133 0.4× 134 0.9× 57 0.5× 209 1.8× 15 864
Yavar Shiravand Italy 7 214 0.6× 493 1.7× 66 0.4× 75 0.6× 147 1.3× 9 844
Vera Balz Germany 17 331 0.9× 364 1.2× 145 1.0× 32 0.3× 49 0.4× 38 838
Fumie Omotehara Japan 17 454 1.3× 253 0.8× 197 1.3× 27 0.2× 65 0.6× 32 769
Takehiro Hayashi Japan 15 394 1.1× 333 1.1× 215 1.4× 25 0.2× 126 1.1× 44 937
Kun-Tu Yeh Taiwan 23 866 2.5× 438 1.5× 346 2.3× 30 0.2× 184 1.6× 43 1.4k
Ivan Vrhovec Slovenia 17 330 0.9× 302 1.0× 523 3.5× 79 0.6× 37 0.3× 34 871

Countries citing papers authored by Tim N. Beck

Since Specialization
Citations

This map shows the geographic impact of Tim N. Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim N. Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim N. Beck more than expected).

Fields of papers citing papers by Tim N. Beck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim N. Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim N. Beck. The network helps show where Tim N. Beck may publish in the future.

Co-authorship network of co-authors of Tim N. Beck

This figure shows the co-authorship network connecting the top 25 collaborators of Tim N. Beck. A scholar is included among the top collaborators of Tim N. Beck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim N. Beck. Tim N. Beck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beck, Tim N., et al.. (2024). Primary thyroid lymphoma: A multi-center retrospective review. The American Journal of Surgery. 237. 115927–115927. 2 indexed citations
2.
3.
Beck, Tim N., et al.. (2023). EUS-guided management of anastomotic stricture: A case report. International Journal of Surgery Case Reports. 106. 108220–108220.
4.
Beck, Tim N., et al.. (2020). Thyroid Cancer Identified After Positron Emission Tomography (PET) Shows Aggressive Histopathology. Journal of Surgical Research. 260. 245–250. 1 indexed citations
5.
Beck, Tim N., Yanis Boumber, Charu Aggarwal, et al.. (2019). Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer. BMC Cancer. 19(1). 603–603. 32 indexed citations
6.
Beck, Tim N., Alexander Y. Deneka, Nicolas J. Alvarez, et al.. (2019). An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion. BMC Cancer. 19(1). 614–614. 5 indexed citations
7.
Beck, Tim N., Alexander E. Kudinov, Essel Dulaimi, & Yanis Boumber. (2019). Case report: reinitiating pembrolizumab treatment after small bowel perforation. BMC Cancer. 19(1). 379–379. 15 indexed citations
8.
Golemis, Erica A., Paul Scheet, Tim N. Beck, et al.. (2018). Molecular mechanisms of the preventable causes of cancer in the United States. Genes & Development. 32(13-14). 868–902. 112 indexed citations
9.
Beck, Tim N., et al.. (2017). Rare antibody-associated hemolytic transfusion reaction and transfusion-related acute lung injury: a case report. BMC Surgery. 17(1). 48–48. 4 indexed citations
10.
Beck, Tim N., Elena Shagisultanova, Elizabeth A. Handorf, et al.. (2016). EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer. Molecular Cancer Therapeutics. 15(10). 2486–2497. 44 indexed citations
11.
Beck, Tim N., Vladislav A. Korobeynikov, Alexander E. Kudinov, et al.. (2016). Anti-Müllerian Hormone Signaling Regulates Epithelial Plasticity and Chemoresistance in Lung Cancer. Cell Reports. 16(3). 657–671. 47 indexed citations
12.
Beck, Tim N. & Erica A. Golemis. (2016). Genomic insights into head and neck cancer. PubMed. 1(1). 69 indexed citations
13.
Deneka, Alexander Y., Tim N. Beck, Hanqing Liu, et al.. (2016). Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin. Oncotarget. 8(12). 19156–19171. 10 indexed citations
14.
Beck, Tim N., Linara Gabitova, & Ilya G. Serebriiskii. (2015). Targeted Therapy: Genomic Approaches. 1. 381–434. 1 indexed citations
15.
Beck, Tim N., Émmanuelle Nicolas, Yan Zhou, Ilya G. Serebriiskii, & Erica A. Golemis. (2015). Abstract 34: AMH and AMHR2 regulate survival signaling, epithelial-mesenchymal transition (EMT) and resistance to HSP90 inhibition in non-small cell lung cancer (NSCLC). Cancer Research. 75(15_Supplement). 34–34.
16.
Beck, Tim N., Émmanuelle Nicolas, Meghan C. Kopp, & Erica A. Golemis. (2014). Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer’s disease. Oncoscience. 1(7). 486–503. 32 indexed citations
17.
Beck, Tim N., et al.. (2014). Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer. Physiological Genomics. 46(19). 699–724. 23 indexed citations
18.
Liu, Hanqing, Tim N. Beck, Erica A. Golemis, & Ilya G. Serebriiskii. (2013). Integrating In Silico Resources to Map a Signaling Network. Methods in molecular biology. 1101. 197–245. 17 indexed citations
19.
Bataille, R, Bart Barlogie, Lu Zy, et al.. (1995). Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma. Blood. 86(2). 685–691. 207 indexed citations
20.
Weikel, W., et al.. (1995). Growth fractions (Ki-67) in primary breast cancers, with particular reference to node-negative tumors.. PubMed. 19(5). 446–50. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026